What is bronchiectasis, and how is it managed?

Written in association with: Dr Tim Gatheral
Published:
Edited by: Conor Lynch

In this article below, highly regarded consultant respiratory physician, Dr Tim Gatheral, tells us about some of the most effective ways one can effectively manage bronchiectasis.

What is bronchiectasis?

Bronchiectasis is a chronic lung condition characterised by the abnormal widening and inflammation of the bronchial tubes, resulting in a build-up of mucus and recurrent lung infections. While bronchiectasis is a lifelong condition with no cure, effective management strategies can help control symptoms, prevent complications, and improve quality of life for individuals living with the condition.

 

What are the best ways one can manage bronchiectasis?

One of the key aspects of managing bronchiectasis is airway clearance techniques. These techniques aim to help remove excess mucus from the lungs, reducing the risk of infections and improving lung function.

 

Common airway clearance techniques include chest physiotherapy, postural drainage, percussion, and vibration. These techniques can be performed independently or with the assistance of a respiratory therapist, and they are typically customised to meet the individual needs and preferences of each patient.

 

In addition to airway clearance techniques, staying hydrated is essential for individuals with bronchiectasis. Drinking plenty of fluids helps to thin mucus secretions, making them easier to clear from the airways.

 

It is also important to avoid environmental irritants and respiratory infections, as these can exacerbate symptoms and increase the risk of flare-ups. Quitting smoking and avoiding exposure to second-hand smoke are also crucial steps in managing bronchiectasis, as smoking can worsen lung function and increase the risk of respiratory infections.

 

Medications may also be prescribed to help manage symptoms and prevent complications in individuals with bronchiectasis. These may include bronchodilators to help open the airways, mucolytics to thin mucus secretions, antibiotics to treat bacterial infections, and corticosteroids to reduce inflammation in the airways. It is important for patients to take their medications as prescribed and to follow up regularly with their healthcare provider to monitor their condition and adjust treatment as needed.

 

Finally, pulmonary rehabilitation programmes can be beneficial for individuals with bronchiectasis, as they provide education, exercise training, and support to help improve lung function, increase exercise tolerance, and enhance overall quality of life. These programs typically involve a multidisciplinary team of healthcare professionals, including respiratory therapists, physiotherapists, and dietitians, who work together to address the diverse needs of patients with bronchiectasis.

 

To make an appointment with Dr Tim Gatheral, head on over to his Top Doctors profile today to do just that. 

By Dr Tim Gatheral
Pulmonology & respiratory medicine

Dr Tim Gatheral is a leading consultant respiratory physician based in Preston, who specialises in chronic cough, breathlessness, bronchiectasis and chronic obstructive pulmonary disease (COPD), as well as interstitial lung disease (ILD) including pulmonary fibrosis. His NHS work is based at Lancashire Teaching Hospitals Trust and University Hospitals of Morecambe Bay NHS Foundation Trust (UHMB).  His private clinic is located at the Greater Lancashire Hospital in Preston. 

Dr Gatheral is highly qualified, with a MA (1999) and MB BChir (2002) from the University of Cambridge. After post-graduate training in London Dr Gatheral undertook a period of research at the National Heart and Lung Institute and Royal Brompton Hospital leading to the award of a PhD from Imperial College London in 2012.

He runs the specialist Interstitial Lung Disease clinic at his NHS hospital, specialising in Idiopathic Pulmonary Fibrosis (IPF), which is a form of ILD characterised by damage to the lung accompanied by an uncontrolled healing response that causes progressive scarring or thickening (fibrosis) of tissues between the lungs' air sacs. 

Dr Gatheral is a respected name in his field as a lead member of the Morecambe Bay Respiratory Network (an integrated respiratory care network promoting excellence in respiratory care diagnosis and management), and also in clinical academia. He is a senior clinical lecturer at Lancaster Medical School where he is co-director of Year 3, and his research has been published in various peer-reviewed journals. He is principle investigator for several university and industry led clinical research trials in Morecambe Bay.

Dr Gatheral has recently been appointed as the director of research and development at UHMB and has held previous managerial roles at the trust including  clinical lead for respiratory medicine.

View Profile

Overall assessment of their patients


  • Related procedures
  • Depression
    Sleep disorders
    Snoring
    Rhinitis
    Obstructive sleep apnea
    Restless legs syndrome
    Autoimmune diseases
    Atypical pneumonia
    Asthma
    Methacholine challenge test
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.